Cleared Traditional

K923121 - QBC HEMACAN HEMATOLOGY SYSTEM

K923121 is an FDA 510(k) clearance for QBC HEMACAN HEMATOLOGY SYSTEM, manufactured by Bd Becton Dickinson Vacutainer Systems Preanalytic. The device is a Class 2 Hematology device with product code GKL cleared through the Traditional 510(k) pathway after a 88-day FDA review.

K923121 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1992
Decision
88d
Days
Class 2
Risk

K923121 is an FDA 510(k) clearance for the QBC HEMACAN HEMATOLOGY SYSTEM. Classified as Counter, Cell, Automated (particle Counter) (product code GKL), Class II - Special Controls.

Submitted by Bd Becton Dickinson Vacutainer Systems Preanalytic (Franklin Lakes, US). The FDA issued a Cleared decision on September 22, 1992 after a review of 88 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5200 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Bd Becton Dickinson Vacutainer Systems Preanalytic devices

FDA 510(k) Submission Details - K923121

510(k) Number K923121 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 26, 1992
Decision Date September 22, 1992
Days to Decision 88 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
25d faster than avg
Panel avg: 113d · This submission: 88d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GKL Device Classification - Class 2, Special Controls

Product Code GKL Counter, Cell, Automated (particle Counter)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GKL Counter, Cell, Automated (particle Counter)

All 82
Devices cleared under the same product code (GKL) and FDA review panel - the closest regulatory comparables to K923121.
RETICULOCYTE METHOD
K954607 · Bayer Corp. · Aug 1996
COULTER Z 1
K952308 · Coulter Corp. · Oct 1995
TECHNICON H* 3TM RTC SYSTEM (IN-VITRO DIAG.SYST.)
K930685 · Heraeus Kulzer, Inc. · Jun 1993
SYSMEX(TM) R-3000 AUTOMATED RETICULOCYTE ANALYZER
K912494 · Toa Medical Electronics USA, Inc. · Sep 1991
SYSMEX F-810
K910849 · Toa Medical Electronics USA, Inc. · Jul 1991
SYSMEX F-610
K911172 · Toa Medical Electronics USA, Inc. · Jul 1991